Alerta Bibliográfica

1. SCHETT G, Saag KG, Bijlsma JW.
From bone biology to clinical outcome: state of the art and future perspectives.
Ann Rheum Dis. 2010;69:1415-9.
http://amedeo.com/p2.php?id=20650876&s=rhe&pm=352014ef2974a30
ABSTRACT available


2. HULTQVIST M, Nandakumar KS, Bjorklund U, Holmdahl R, et al.
Rabeximod reduces arthritis severity in mice by decreasing activation of
inflammatory cells.
Ann Rheum Dis. 2010;69:1527-32.
http://amedeo.com/p2.php?id=20542961&s=rhe&pm=352014ef2974a30
ABSTRACT available


3. VILCA I, Munitis PG, Pistorio A, Ravelli A, et al.
Predictors of poor response to methotrexate in polyarticular-course juvenile
idiopathic arthritis: analysis of the PRINTO methotrexate trial.
Ann Rheum Dis. 2010;69:1479-83.
http://amedeo.com/p2.php?id=20525842&s=rhe&pm=352014ef2974a30
ABSTRACT available


4. FREY O, Meisel J, Hutloff A, Bonhagen K, et al.
Inducible costimulator (ICOS) blockade inhibits accumulation of polyfunctional T
helper 1/T helper 17 cells and mitigates autoimmune arthritis.
Ann Rheum Dis. 2010;69:1495-501.
http://amedeo.com/p2.php?id=20498202&s=rhe&pm=352014ef2974a30
ABSTRACT available


5. VAN DER WOUDE D, Rantapaa-Dahlqvist S, Ioan-Facsinay A, Onnekink C, et al.
Epitope spreading of the anti-citrullinated protein antibody response occurs
before disease onset and is associated with the disease course of early
arthritis.
Ann Rheum Dis. 2010;69:1554-61.
http://amedeo.com/p2.php?id=20448290&s=rhe&pm=352014ef2974a30
ABSTRACT available


6. THURLINGS RM, Boumans M, Tekstra J, van Roon JA, et al.
The relationship between the type I interferon signature and the response to
rituximab in rheumatoid arthritis.
Arthritis Rheum. 2010.
http://amedeo.com/p2.php?id=20722020&s=rhe&pm=352014ef2974a30
ABSTRACT available


7. BOERS M, Kostense PJ.
Non-overlapping ACR response rates: A better way to report response in rheumatoid
arthritis clinical trials.
Arthritis Rheum. 2010.
http://amedeo.com/p2.php?id=20722016&s=rhe&pm=352014ef2974a30
ABSTRACT available


8. MIKULS TR, Sayles H, Yu F, Levan T, et al.
Associations of cigarette smoking with rheumatoid arthritis in African Americans.
Arthritis Rheum. 2010.
http://amedeo.com/p2.php?id=20722010&s=rhe&pm=352014ef2974a30
ABSTRACT available


9. STRAND V, Khanna D.
The impact of rheumatoid arthritis and treatment on patients' lives.
Clin Exp Rheumatol. 2010;28.
http://amedeo.com/p2.php?id=20576223&s=rhe&pm=352014ef2974a30
ABSTRACT available


10. SMOLEN JS, Aletaha D.
The assessment of disease activity in rheumatoid arthritis.
Clin Exp Rheumatol. 2010;28.
http://amedeo.com/p2.php?id=20576221&s=rhe&pm=352014ef2974a30
ABSTRACT available


11. FURST DE.
Development of TNF inhibitor therapies for the treatment of rheumatoid arthritis.
Clin Exp Rheumatol. 2010;28.
http://amedeo.com/p2.php?id=20576219&s=rhe&pm=352014ef2974a30
ABSTRACT available


12. FERRARI R, Russell AS.
Correlations between coping styles and symptom expectation for rheumatoid
arthritis.
Clin Rheumatol. 2010.
http://amedeo.com/p2.php?id=20714764&s=rhe&pm=352014ef2974a30
ABSTRACT available


13. KOLLY L, Busso N, Palmer G, Talabot-Ayer D, et al.
Expression and function of the NALP3 inflammasome in rheumatoid synovium.
Immunology. 2010;129:178-85.
http://amedeo.com/p2.php?id=19824913&s=rhe&pm=352014ef2974a30
ABSTRACT available


14. OSTILE IL, Johansson I, Aasland A, Flato B, et al.
Self-rated physical and psychosocial health in a cohort of young adults with
juvenile idiopathic arthritis.
Scand J Rheumatol. 2010;39:318-25.
http://amedeo.com/p2.php?id=20476866&s=rhe&pm=352014ef2974a30
ABSTRACT available


-- Desde Mi iPhone

Alerta Bibliográfica

Cortesía de AMEDEO


1. MARTINI A, Lovell DJ.
Juvenile idiopathic arthritis: state of the art and future perspectives.
Ann Rheum Dis. 2010;69:1260-3.
http://amedeo.com/p2.php?id=20525835&s=rhe&pm=352014ef2974a30
ABSTRACT available


2. TAKAGI Y, Kimura Y, Nakamura H, Sasaki M, et al.
Salivary gland ultrasonography: can it be an alternative to sialography as an
imaging modality for Sjogren's syndrome?
Ann Rheum Dis. 2010;69:1321-4.
http://amedeo.com/p2.php?id=20498211&s=rhe&pm=352014ef2974a30
ABSTRACT available


3. VASSILOPOULOS D, Apostolopoulou A, Hadziyannis E, Papatheodoridis GV, et al.
Long-term safety of anti-TNF treatment in patients with rheumatic diseases and
chronic or resolved hepatitis B virus infection.
Ann Rheum Dis. 2010;69:1352-5.
http://amedeo.com/p2.php?id=20472596&s=rhe&pm=352014ef2974a30
ABSTRACT available


4. POTTER C, Cordell HJ, Barton A, Daly AK, et al.
Association between anti-tumour necrosis factor treatment response and genetic
variants within the TLR and NF{kappa}B signalling pathways.
Ann Rheum Dis. 2010;69:1315-20.
http://amedeo.com/p2.php?id=20448286&s=rhe&pm=352014ef2974a30
ABSTRACT available


5. NG CT, Biniecka M, Kennedy A, McCormick J, et al.
Synovial tissue hypoxia and inflammation in vivo.
Ann Rheum Dis. 2010;69:1389-95.
http://amedeo.com/p2.php?id=20439288&s=rhe&pm=352014ef2974a30
ABSTRACT available


6. PETERS MJ, Welsh P, McInnes IB, Wolbink G, et al.
Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain
natriuretic peptide levels in patients with active rheumatoid arthritis: results
from a prospective cohort study.
Ann Rheum Dis. 2010;69:1281-5.
http://amedeo.com/p2.php?id=19934107&s=rhe&pm=352014ef2974a30
ABSTRACT available


7. EYRE S, Flynn E, Martin P, Hinks A, et al.
No evidence for association of the KLF12 gene with rheumatoid arthritis in a
large UK cohort.
Ann Rheum Dis. 2010;69:1407-8.
http://amedeo.com/p2.php?id=19907058&s=rhe&pm=352014ef2974a30



8. STEFAN B, Caroline O, Christoph R.
"Inhibition of fibroblast activation protein and dipeptidyl peptidase IV
increases cartilage invasion by rheumatoid arthritis synovial fibroblasts"
Arthritis Rheum. 2010.
http://amedeo.com/p2.php?id=20669287&s=rhe&pm=352014ef2974a30



9. JAKOBS M, Fritsche R.
Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases
cartilage invasion by rheumatoid arthritis synovial fibroblasts: Comment on the
article by Ospelt et al.
Arthritis Rheum. 2010.
http://amedeo.com/p2.php?id=20669284&s=rhe&pm=352014ef2974a30



10. GERLAG DM, Hollis S, Layton M, Vencovsky J, et al.
Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients
with rheumatoid arthritis receiving methotrexate.
Arthritis Rheum. 2010.
http://amedeo.com/p2.php?id=20662070&s=rhe&pm=352014ef2974a30
ABSTRACT available


11. ABREU JR, Krausz S, Dontje W, Grabiec AM, et al.
Sustained T cell Rap1 signaling is protective in the collagen-induced arthritis
model of rheumatoid arthritis.
Arthritis Rheum. 2010.
http://amedeo.com/p2.php?id=20662068&s=rhe&pm=352014ef2974a30
ABSTRACT available


12. LUNT M, Watson KD, Dixon WG, Symmons DP, et al.
No evidence of association between anti-TNF treatment and mortality in patients
with rheumatoid arthritis: Results from the British Society for Rheumatology
Biologics Register.
Arthritis Rheum. 2010.
http://amedeo.com/p2.php?id=20662063&s=rhe&pm=352014ef2974a30
ABSTRACT available


13. MANNIK M.
Antibodies to several citrullinated antigens are enriched in the joints of
rheumatoid arthritis patients: Comments on the article by Snir et al.
Arthritis Rheum. 2010.
http://amedeo.com/p2.php?id=20662055&s=rhe&pm=352014ef2974a30



14. GUO F, Lai Y, Tian Q, Lin EA, et al.
Granulin-epithelin precursor binds directly to ADAMTS-7 and ADAMTS-12 and
inhibits their degradation of cartilage oligomeric matrix protein.
Arthritis Rheum. 2010;62:2023-36.
http://amedeo.com/p2.php?id=20506400&s=rhe&pm=352014ef2974a30
ABSTRACT available


15. AIROLDI I, Di Carlo E, Pistoia V.
The enigmatic role of interleukin-12 in the pathogenesis of Sjogren's syndrome:
comment on the article by Vosters et al.
Arthritis Rheum. 2010;62:2180.
http://amedeo.com/p2.php?id=20506334&s=rhe&pm=352014ef2974a30



16. RAPTOPOULOU AP, Bertsias G, Makrygiannakis D, Verginis P, et al.
The programmed death 1/programmed death ligand 1 inhibitory pathway is
up-regulated in rheumatoid synovium and regulates peripheral T cell responses in
human and murine arthritis.
Arthritis Rheum. 2010;62:1870-80.
http://amedeo.com/p2.php?id=20506224&s=rhe&pm=352014ef2974a30
ABSTRACT available


17. THOMPSON AE, Bashook PG.
Rheumatologists' recommended patient information when prescribing methotrexate
for rheumatoid arthritis.
Clin Exp Rheumatol. 2010.
http://amedeo.com/p2.php?id=20663404&s=rhe&pm=352014ef2974a30
ABSTRACT available


18. MAGNANI A, Pattacini L, Boiardi L, Casali B, et al.
Reelin levels are increased in synovial fluid of patients with rheumatoid
arthritis.
Clin Exp Rheumatol. 2010.
http://amedeo.com/p2.php?id=20659411&s=rhe&pm=352014ef2974a30
ABSTRACT available


19. ALOUSH V, George J, Elkayam O, Wigler I, et al.
Decreased levels of CCR3 in CD4+ lymphocytes of rheumatoid arthritis patients.
Clin Exp Rheumatol. 2010.
http://amedeo.com/p2.php?id=20659406&s=rhe&pm=352014ef2974a30
ABSTRACT available


20. GRONNING K, Rodevand E, Steinsbekk A.
Paid work is associated with improved health-related quality of life in patients
with rheumatoid arthritis.
Clin Rheumatol. 2010.
http://amedeo.com/p2.php?id=20645116&s=rhe&pm=352014ef2974a30
ABSTRACT available


21. MORISHITA K, Petty R, Cairns R, Bolaria R, et al.
Serious musculoskeletal infections in children receiving anti-tumor necrosis
factor-alpha therapy: a case series.
Clin Rheumatol. 2010;29:677-81.
http://amedeo.com/p2.php?id=20383549&s=rhe&pm=352014ef2974a30
ABSTRACT available


22. ZHOU JG, Qing YF, Jiang L, Yang QB, et al.
Clinical analysis of primary Sjogren's syndrome complicating anemia.
Clin Rheumatol. 2010;29:525-9.
http://amedeo.com/p2.php?id=20174847&s=rhe&pm=352014ef2974a30
ABSTRACT available


23. CALICH AL, Domiciano DS, Fuller R.
Osteoarthritis: can anti-cytokine therapy play a role in treatment?
Clin Rheumatol. 2010;29:451-5.
http://amedeo.com/p2.php?id=20108016&s=rhe&pm=352014ef2974a30
ABSTRACT available


24. SLIMANI S, Ben Ammar A, Ladjouze-Rezig A.
Connective tissue diseases after heavy exposure to silica: a report of nine cases
in stonemasons.
Clin Rheumatol. 2010;29:531-3.
http://amedeo.com/p2.php?id=20108013&s=rhe&pm=352014ef2974a30



25. KIM JS, Lee SS, Kim TJ, Park YW, et al.
Serum hyaluronic acid levels do not explain morning stiffness in patients with
fibromyalgia.
Clin Rheumatol. 2010;29:535-9.
http://amedeo.com/p2.php?id=20094744&s=rhe&pm=352014ef2974a30
ABSTRACT available


26. AKBULUT H, Koca SS, Ozgen M, Isik A, et al.
Anti-tumor necrosis factor therapies reduce serum macrophage inflammatory
protein-1alpha in ankylosing spondylitis.
J Rheumatol. 2010;37:1073-4.
http://amedeo.com/p2.php?id=20439531&s=rhe&pm=352014ef2974a30



27. LEOMBRUNO J.
The challenges of quantifying the risk of serious infection with tumor necrosis
factor antagonist therapy.
J Rheumatol. 2010;37:887-9.
http://amedeo.com/p2.php?id=20439519&s=rhe&pm=352014ef2974a30



28. BOWMAN SJ, St Pierre Y, Sutcliffe N, Isenberg DA, et al.
Estimating indirect costs in primary Sjogren's syndrome.
J Rheumatol. 2010;37:1010-5.
http://amedeo.com/p2.php?id=20360188&s=rhe&pm=352014ef2974a30
ABSTRACT available


29. PALOMINO-MORALES RJ, Diaz-Gallo LM, Witte T, Anaya JM, et al.
Influence of STAT4 polymorphism in primary Sjogren's syndrome.
J Rheumatol. 2010;37:1016-9.
http://amedeo.com/p2.php?id=20360187&s=rhe&pm=352014ef2974a30
ABSTRACT available


30. HEALD AE, Fudman EJ, Anklesaria P, Mease PJ, et al.
Single-joint outcome measures: preliminary validation of patient-reported
outcomes and physical examination.
J Rheumatol. 2010;37:1042-8.
http://amedeo.com/p2.php?id=20231202&s=rhe&pm=352014ef2974a30
ABSTRACT available


31. JUNG SY, Park YB, Ha YJ, Lee KH, et al.
Serum calprotectin as a marker for disease activity and severity in adult-onset
Still's disease.
J Rheumatol. 2010;37:1029-34.
http://amedeo.com/p2.php?id=20231196&s=rhe&pm=352014ef2974a30
ABSTRACT available


32. KAVANAUGH A, Lee SJ, Weng HH, Chon Y, et al.
Patient-derived joint counts are a potential alternative for determining Disease
Activity Score.
J Rheumatol. 2010;37:1035-41.
http://amedeo.com/p2.php?id=20156946&s=rhe&pm=352014ef2974a30
ABSTRACT available


33. ANDERSON ST.
Changes in overall health may have caused recent declines in erythrocyte
sedimentation rate in patients with rheumatoid arthritis.
J Rheumatol. 2010;37:1064.
http://amedeo.com/p2.php?id=19332628&s=rhe&pm=352014ef2974a30



34. RAHME E, Bernatsky S.
NSAIDs and risk of lower gastrointestinal bleeding.
Lancet. 2010;376:146-8.
http://amedeo.com/p2.php?id=20638554&s=rhe&pm=352014ef2974a30



35. ARIF S, Cox P, Afzali B, Lombardi G, et al.
Anti-TNFalpha therapy--killing two birds with one stone?
Lancet. 2010;375:2278.
http://amedeo.com/p2.php?id=20609973&s=rhe&pm=352014ef2974a30



36. LENG RX, Pan HF, Tao JH, Ye DQ, et al.
Cholecystokinin octapeptide (CCK-8): friend or foe for rheumatoid arthritis?
Rheumatol Int. 2010.
http://amedeo.com/p2.php?id=20668859&s=rhe&pm=352014ef2974a30



37. ZHOU Y, Zuo X, Li Y, Wang Y, et al.
Nicotine inhibits tumor necrosis factor-alpha induced IL-6 and IL-8 secretion in
fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Rheumatol Int. 2010.
http://amedeo.com/p2.php?id=20665032&s=rhe&pm=352014ef2974a30
ABSTRACT available


38. LEE KA, Bang SY, Park BL, Kim JH, et al.
Lack of association between Poly(ADP-ribose) polymerase (PARP) polymorphisms and
rheumatoid arthritis in a Korean population.
Rheumatol Int. 2010.
http://amedeo.com/p2.php?id=20665026&s=rhe&pm=352014ef2974a30
ABSTRACT available


39. HEIN G, Eidner T, Oelzner P, Rose M, et al.
Influence of Rituximab on markers of bone remodeling in patients with rheumatoid
arthritis: a prospective open-label pilot study.
Rheumatol Int. 2010.
http://amedeo.com/p2.php?id=20661741&s=rhe&pm=352014ef2974a30
ABSTRACT available


40. RODRIGUEZ-RODRIGUEZ L, Lamas JR, Varade J, Lopez-Romero P, et al.
Plasma soluble IL-6 receptor concentration in rheumatoid arthritis: associations
with the rs8192284 IL6R polymorphism and with disease activity.
Rheumatol Int. 2010.
http://amedeo.com/p2.php?id=20661738&s=rhe&pm=352014ef2974a30
ABSTRACT available


41. LU C, Xiao C, Chen G, Jiang M, et al.
Cold and heat pattern of rheumatoid arthritis in traditional Chinese medicine:
distinct molecular signatures indentified by microarray expression profiles in
CD4-positive T cell.
Rheumatol Int. 2010.
http://amedeo.com/p2.php?id=20658292&s=rhe&pm=352014ef2974a30
ABSTRACT available


42. KOPEC-MEDREK M, Widuchowska M, Kotulska A, Zycinska-Debska E, et al.
Serum cystatin C level in patients with rheumatoid arthritis after single
infusion of infliximab.
Rheumatol Int. 2010.
http://amedeo.com/p2.php?id=20658289&s=rhe&pm=352014ef2974a30



43. MALYSHEVA O, Pierer M, Wagner U, Baerwald CG, et al.
[Stress and rheumatoid arthritis.]
Z Rheumatol. 2010.
http://amedeo.com/p2.php?id=20652573&s=rhe&pm=352014ef2974a30
ABSTRACT available

Ubicación:1a. Priv. de Florencia,Cuernavaca,México